Press and news
Mercyhealth deploys Molekule's breakthrough air purification systems, including new Molekule Air Pro RX, to enhance protection for its frontline healthcare workers in wake of COVID-19.
Molekule launches new commercial product, Air Pro RX, with FDA 510(k) class II medical device clearance.
Molekule announces new home product, Air Mini+, bringing sensor technology and automation to Air Mini line in response to high customer demand.
National laboratory study finds that Molekule Air purifier effectively eliminates common volatile organic chemicals (VOCs) and ozone in a Room-Sized Environment.
Air purification innovator, Molekule, secures $58 Million in series C financing, signaling strong investor backing in the fight for clean air.
